Since both DKK1 and sFRP2 are established targets of TCF/β-catenin-mediated transcription [18]–[20], these findings suggests the presence of a negative feedback loop in MM in which DKK1 and sFRP2 act as potential tumor suppressors. This evidence concerns the gene SFRP2 and Miyoshi myopathy.